FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: LOE ApproachingClear all
DEMSER
metyrosine
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
the treatment of patients with pheochromocytoma for: 1hypertension
1979
NDA
30/100
DEMULEN 1/35-21
ethinyl estradiol; ethynodiol diacetate
LOE Approaching
Pfizer
ORAL-21 · TABLET
pregnancy
1981
NDA
30/100
DEMULEN 1/35-28
ethinyl estradiol; ethynodiol diacetate
LOE Approaching
Pfizer
ORAL-28 · TABLET
pregnancy
1981
NDA
30/100
DEMULEN 1/50-21
ethinyl estradiol; ethynodiol diacetate
LOE Approaching
Pfizer
ORAL-21 · TABLET
pregnancy
1970
NDA
30/100
DEMULEN 1/50-28
ethinyl estradiol; ethynodiol diacetate
LOE Approaching
Pfizer
ORAL-28 · TABLET
pregnancy
1970
NDA
30/100
DENAVIR
penciclovir
LOE Approaching
Viatris (2)
TOPICAL · CREAM
recurrent herpes labialis (cold sores) in adultsolder
1996
SMNDA
30/100
DENDRID
idoxuridine
LOE Approaching
Alcon
OPHTHALMIC · SOLUTION/DROPS
1963
NDA
30/100
DENTIPATCH
lidocaine
LOE Approaching
Noven Pharmaceuticals
BUCCAL · FILM, EXTENDED RELEASE
1996
NDA
30/100
DEPACON
valproate sodium
LOE Approaching
AbbVie
INJECTION · INJECTABLE
womenwomen of childbearing potential+5
1996
NDA
30/100
DEPAKENE
valproic acid
LOE Approaching
AbbVie
ORAL · SYRUP
womenwomen of childbearing potential+5
1978
NDA
30/100
DEPAKENE
valproic acid
LOE Approaching
AbbVie
ORAL · CAPSULE
womenwomen of childbearing potential+5
1978
NDA
30/100
DEPAKOTE
divalproex sodium
LOE Approaching
AbbVie
ORAL · TABLET, DELAYED RELEASE
the manic episodes associated with bipolar disordermigraine headaches+7
1983
NDA
30/100
DEPAKOTE
divalproex sodium
LOE Approaching
AbbVie
ORAL · CAPSULE, DELAYED REL PELLETS
womenwomen of childbearing potential+5
1989
NDA
30/100
DEPAKOTE CP
divalproex sodium
LOE Approaching
Abbott
ORAL · TABLET, DELAYED RELEASE
acute manicmixed episodes associated with bipolar disorder+10
1990
NDA
30/100
DEPAKOTE ER
divalproex sodium
LOE Approaching
AbbVie
ORAL · TABLET, EXTENDED RELEASE
acute manicmixed episodes associated with bipolar disorder+10
2008
NDA
30/100
DEPAKOTE ER
divalproex sodium
LOE Approaching
Abbott
Oral · Tablet, Extended Release
acute manicmixed episodes associated with bipolar disorder+10
2002
NDA
30/100
DEPAKOTE ER
divalproex sodium
LOE Approaching
AbbVie
ORAL · TABLET, EXTENDED RELEASE
acute manicmixed episodes associated with bipolar disorder+10
2000
NDA
30/100
DEPEN
penicillamine
LOE Approaching
Viatris (2)
ORAL · TABLET
the treatment of Wilson's diseasecystinuria+5
1978
NDA
30/100
DEPO-MEDROL
methylprednisolone acetate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
dermatomyositispolymyositis+14
1959
NDA
30/100
DEPO-PROVERA
medroxyprogesterone acetate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
pregnancymethod unless other options are considered inadequate+1
1960
NDA
30/100
DEPO-PROVERA
medroxyprogesterone acetate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
pregnancymethod unless other options are considered inadequate+1
1992
NDA
30/100
DEPO-SUBQ PROVERA 104
medroxyprogesterone acetate
LOE Approaching
Pfizer
SUBCUTANEOUS · INJECTABLE
pregnancy andendometriosis-associated pain+6
2004
NDA
30/100
DEPO-TESTADIOL
estradiol cypionate; testosterone cypionate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of: 1
1980
NDA
30/100
DEPOCYT
cytarabine
LOE Approaching
INJECTION · INJECTABLE, LIPOSOMAL
newly diagnosed therapy-related acute myeloid leukemia (t-AML)AML with myelodysplasia-related changes (AML-MRC) in adults+2
1999
NDA
30/100
← PreviousPage 43 of 188Next →